Wednesday, 11 September 2024

August’s busiest US investors

Plus, the founder perks of early-stage VC

September 11, 2024

Hi, Agen. It turns out August’s busiest U.S. investors weren’t very busy at all, with only one firm hitting double digits last month. Of course, most of the activity involved the AI sector, but fintech and blockchain also got some investor attention. Plus, an AI unicorn more than doubled its valuation in just seven months with a $260 million-plus Series E. And guest author Marc Schröder shares the multistage challenges founders face.

💰 Most-active US investors in August

August seems to have been a slow month all the way around. Funding overall was down for the month, and in the U.S. no investor consummated very many deals.

🔥 AI enterprise Glean sees massive valuation jump to $4.6B

Less than seven months after raising a more than $200 million Series D at a $2.2 billion valuation, AI-enhanced work assistant and enterprise search startup Glean raised more than $260 million in a Series E funding at a $4.6 billion valuation co-led by Altimeter Capital and DST Global.

Related Crunchbase Pro list: Rounds Raised By Startups Using AI

🍀 Startup founder perks of early-stage VC

Getting the right investors at the right time can be vital to a startup’s success, especially during the early stages, writes MGV’s Marc Schröder, who lays out the multistage challenges founders face.

🩺 VCs pour more money into self-pay healthcare

With out-of-pocket health spending and high-deductible health plans on the rise, more U.S. venture investment is going to companies innovating around these themes. Consumers aren’t exactly elated at the trend.

Related Crunchbase Pro list: Funded Companies Tied To Self-Pay And High-Deductible Health Coverage

✂️ Hundreds of West Coast workers lost their jobs last week

While layoffs continue to rock the U.S. tech sector, last week did not see more than one company from a particular sector reporting cuts. However, some of the layoffs involved a substantial number of workers. We take a look.

Recent Investments

Superluminal Medicines

$120M / Series A

Superluminal Medicines is a generative biological and chemical company that innovates drug discovery and development processes.

Categories:

Biotechnology • Medical • Pharmaceutical

Founders:

Ajay Yekkirala, Cony D'Cruz

Investors:

RA Capital Management (Lead), Catalio Capital Management, Cooley + 4 more

AppsForBharat

1.5B INR / Series B

AppsForBharat mobile app developer that caters to the spiritual and devotional needs of its users.

Categories:

Apps • Information Technology • Internet • Mobile Apps • Software

Founders:

Prashant Sachan

Investors:

Fundamentum (Lead), Elevation Capital, Mirae Asset + 2 more

Scientia Vascular

$14M / Private Equity Round

Scientia Vascular is a medical device company that provides endovascular devices that assist in complex and minimally invasive procedures.

Categories:

Health Care • Manufacturing • Medical • Medical Device

Founders:

John Lippert

Investors:

Piper Jaffray Merchant Banking (Lead)

More Fundings

Company Amount / Round Lead Investor
SafetyCulture 90M AUD / Secondary Market -
SafetyCulture 75M AUD / Venture Round Airtree Ventures
FlapKap $34M / Seed Round BECO Capital
Twenty7Tec 16M GBP / Venture Round Business Growth Fund
Tab Commerce $2.5M / Seed Round Toba Capital
NFWF $2.0M / Grant -
All Recent Funding Activity

Recent Acquisitions

Centamin

Pending acquisition by AngloGold Ashanti for $2.5B

More Acquisitions

Company Acquired By Amount
ShareFile Progress $875M
SDI - Polarizing Film Business Wuxi Hengxin Optoelectronic Materials $836M
All Recent Acquisition Activity

Upcoming Tech Events

Forbes Under 30 Summit

September 22 - 25, 2024 in Philadelphia

Forbes Under 30 Summit convening more than 2,000 of the planet’s top young entrepreneurs and game-changers, as well as world-class mentors.

Accelerator Deadlines

Date Accelerator Location
Apr 5, 2027 Evvolve & Partners London
Mar 2, 2028 Desi Beats Tours And Travel Unknown
More Upcoming Deadlines
Don’t see your event? Reach out to us at events@crunchbase.com.

Discover innovative companies and the people behind them.

Follow Us on Crunchbase View Jobs on LinkedIn Follow Us on Twitter Like Us on Facebook

564 Market St, San Francisco, CA 94104
© 2024 Crunchbase Inc. All rights reserved. Privacy Policy | Terms of Service

Unsubscribe from Crunchbase Daily.

No comments:

Post a Comment